Opening the Floodgates to T Cells – Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC

Jeffrey Wallin, Ph.D. of Genentech presents "Opening the Floodgates to T Cells – Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC" at the 14th International Kidney Cance... Author: kidneycancer Added: 11/07/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts